Related Experiment Video
Updated: Jan 20, 2026

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides
Published on: May 7, 2020
Improving Patient Participation in Cancer Clinical Trials: A Qualitative Analysis of HSRProj & RePORTER
Lynette Hammond Gerido1, Zhe He1
1School of Information, Florida State University, Tallahassee, Florida, 32306 USA.
Abstract:
Enrollment and representativeness, in cancer trials, have been a problem resulting in studies with poor generalizability to the real-world population. This study uses qualitative analysis of two publicly available datasets (HSRProj and RePORTER) to explore funded research projects, which employ strategies at the macro, meso, and micro levels. Our research shows that although the number of projects designed to increase participation in cancer clinical trials peaked in the 2000s, most employ a single level strategy.
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Qualitative Analysis
For instance, group IV...
Qualitative Analysis
There are two main approaches to qualitative analysis:...
Statistical Software for Data Analysis and Clinical Trials
Data Reporting and Recording

